Primary Record
251647-48-0
- In stock
- 5,942 g
- Purity
- 99.1 %
- CAS
- 251647-48-0
Compound Identifiers & Properties
- CAS
- 251647-48-0
- PubChem CID
- 21107951
- SMILES
- COCCO[C@@H]1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)NC(=O)C4=CC=CC=C4)COC(C5=CC=CC=C5)(C6=CC=C(C=C6)OC)C7=CC=C(C=C7)OC)O
- Canonical SMILES
- COCCO[C@@H]1[C@H](O)[C@@H](COC(c2ccccc2)(c2ccc(OC)cc2)c2ccc(OC)cc2)O[C@H]1n1cnc2c(NC(=O)c3ccccc3)ncnc21
Names & Synonyms
- 251647-48-0
- N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)Adenosine
- MFCD14586330
- orb1908045
- SCHEMBL1040958
- SCHEMBL30200670
- CTK4F5107
- DTXSID00610825
- KEVMXGNDTKPSMC-MUMPVVMASA-N
- C41H41N5O8
- N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide
- AKOS025401693
- ZINC150339667
- AM10135
- NB16316
- N-benzoyl-5'-O-DMTr-2'-O-(2-methoxyethyl)-adenosine
- AC-24672
- AS-46877
- SY244171
- DB-067329
- F10802
- N-benzoyl-5-O-DMTr-2-O-(2-methoxyethyl)-Adenosine
- A855684
- F986727
- N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-(2-methoxyethoxy)oxolan-2-yl]purin-6-yl]benzamide
- N-Benzoyl-5'-O-DMTr-2'-O-(2-methoxyethyl)adenosine
- N-Benzoyl-5'-ODMTr-2'-O-(2-methoxyethyl)-adenosine
- N-Benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)-adenosine
- n6-benzoyl-5'-o-(4,4'-dimethoxytrityl)-2'-o-(2-methoxyethyl)adenosine
- Adenosine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)-
- N-Benzoyl-5'-o-(bis(4-methoxyphenyl)phenylmethyl)-2'-o-(2-methoxyethyl)adenosine
- N-Benzoyl-5'-O-[bis(4-methoxyphenyl)(phenyl)methyl]-2'-O-(2-methoxyethyl)adenosine
- N-Benzoyl-5'-O-bis(4-methoxyphenyl)phenylmethyl-2'-O-(2-methoxyethyl)-adenosine
- ADENOSINE, N-BENZOYL-5'-O-[BIS(4-METHOXYPHENYL)PHENYLMETHYL]-2'-O-(2-METHOXYETHYL)- (9CI)
- N-(9-((2R,3R,4R,5R)-5-((bis(4-Methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide; N-Benzoyl-5'-O-DMTR-2'-O-(2-methoxyethyl)-adenosine; 17: PN: US20030211606 PAGE: 19 claimed sequence; 18: PN: US20040005569 PAGE: 22 claimed sequence; 20: PN: US20040006030 PAGE: 23 claimed sequence; 20: PN: US20040014047 PAGE: 21 claimed sequence; 20: PN: US20040014049 PAGE: 21 claimed sequence; 21: PN: US20040005570 PAGE: 20 claimed sequence; 21: PN: US20040014048 PAGE: 21 claimed sequence; 21: PN: US20040014050 PAGE: 20 claimed sequence; 22: PN: US20040005565 PAGE: 17-22 claimed sequence; 22: PN: US20040014051 PAGE: 23 claimed sequence; 23: PN: US20040014699 PAGE: 20 claimed sequence; 24: PN: US20040006029 PAGE: 23 claimed sequence; 24: PN: WO03106645 PAGE: 73 claimed sequence; 95: PN: US20040005707 PAGE: 20 claimed sequence
- N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenyl-methoxy]methyl]-4-hydroxy-3-(2-methoxyethoxy)tetrahydrofuran-2-yl]purin-6-yl]benzamide
- N-{9-[(2R,3R,4R,5R)-5-{[bis(4-methoxyphenyl)(phenyl)methoxy]methyl}-4-hydroxy-3-(2-methoxyethoxy)oxolan-2-yl]purin-6-yl}benzamide
- N-Benzoyl-5 inverted exclamation mark -O-[bis(4-methoxyphenyl)phenylmethyl]-2 inverted exclamation mark -O-(2-methoxyethoxy)adenosine